Ipksindia !!install!! | QUICK |

She was testing a batch of a common antimalarial drug, Artesunate, sent from a manufacturer in Nagpur. The label claimed it contained 500 mg of active ingredient. The machine said 120 mg. The rest was cheap fillers—chalk, starch, and a nasty binder that could cause kidney failure.

The fluorescent lights of the IPC Reference Lab in Ghaziabad hummed a low, steady note. Dr. Ananya Sharma stared at the High-Performance Liquid Chromatography (HPLC) readout, and her blood ran cold. ipksindia

“Sir, you need to see this,” she said, walking into the office of Dr. K. S. Rajan, the secretary-cum-scientific director of the IPC. She was testing a batch of a common

She volunteered to join the inspection team. They drove eight hours to Nagpur, to the “Shree Pharma” factory. The owner, a portly man named Mr. Mehta, met them with sweet tea and a wide, oily smile. The rest was cheap fillers—chalk, starch, and a

Within four hours, the system went live. Ananya uploaded the “Drug Alert” onto the IPC’s website, flagging the specific batch number. This wasn't a suggestion. Under the Drugs and Cosmetics Act, this alert forced every state drug controller from Kerala to Kashmir to seize that batch from every pharmacy shelf.

Rajan adjusted his glasses, looking at the data. He didn't sigh or curse. He simply nodded. “The quality control failure is theirs. The public health failure is ours to prevent. Issue the alert.”